市场调查报告书
商品编码
1380446
全球无创减脂市场2023-2030Global Non-Invasive Fat Reduction Market 2023-2030 |
预计全球非侵入性减脂市场在预测期内(2023-2030年)将以7.8%的CAGR成长。推动市场成长的关键因素包括肥胖盛行率上升、健康风险意识不断增强、对微创手术的需求不断增长以及非侵入性减脂手术的采用率不断上升。根据国际美容整形外科学会的数据,2022 年非手术减脂手术总数为 778,716 例,较 2021 年的 730,980 例有所增加。此外,一项调查显示,85% 的人有一个开始思考更多的季节关于摆脱顽固的身体脂肪,对于其中40% 的人来说,这个季节就是春天。此外,92% 的人希望得到帮助让自己的身体为夏季做好准备。因此,製造商正在推出活动来鼓励那些正在寻求非侵入性减脂治疗的人。例如,2023 年 4 月,AbbVie 旗下公司、CoolSculpting (R) Elite 的母公司 Allergan Aesthetics 推出了首个 CoolMonth。 CoolMonth 活动鼓励正在考虑非侵入性塑身治疗的人们与值得信赖的医疗保健提供者进行对话,并就如何实现其塑身目标进行公开对话。
全球非侵入性减脂市场按技术和最终用户进行细分。根据技术,市场细分为冷冻溶脂、超音波等。此外,根据最终用户,市场细分为医院、美容诊所等。在最终用户中,由于设备齐全、交通便利、信任和可靠,预计医院细分市场将占据相当大的市场份额。
其中,冷冻溶脂细分领域预计将在全球非侵入性减脂市场中占据相当大的份额。细分市场的成长归因于副作用最小,以及对安全、快速和非侵入性治疗的需求不断增长。根据国家医学图书馆的研究,冷冻溶脂是一种有前景的非手术减脂方法,是抽脂和其他侵入性方法的替代方法。该手术在短期内似乎是安全的,副作用有限,并且当用于局部肥胖时可显着减少脂肪。目前尚不清楚治疗后手动按摩和同一解剖区域的多次治疗是否可以增强冷冻溶脂的功效。
全球非侵入性减脂市场根据地理位置进一步细分,包括北美(美国和加拿大)、欧洲(英国、义大利、西班牙、德国、法国和欧洲其他地区)、亚太地区(印度、中国、日本、韩国和亚洲其他地区)以及世界其他地区(中东和非洲以及拉丁美洲)。其中,亚太地区预计将在全球市场中占据显着份额,因为随着人们对美容治疗益处的认识不断提高、对完美外表和通过身体特征获得自信的渴望不断增强,以及新兴经济体城市化带来的可支配收入的增加和生活方式的改变,正在推动亚太地区的非侵入性减脂市场。
在所有地区中,欧洲地区预计在预测期内将以相当大的CAGR成长。由于肥胖病例增加和微创手术越来越多地采用等因素,欧洲市场正在成长。根据国际美容整形外科学会2022年报告,2022年,英国非手术减脂手术总数为2,142例,其次是德国非手术减脂手术总数为26,989例,在义大利,非手术减脂手术总数为 13,071 例。此外,市场参与者高度集中于关键产品的推出和收购以及扩大欧洲市场的合作伙伴关係是推动该地区非侵入性减脂市场成长的一些因素。例如,2020 年 9 月,美容、外科和眼科应用领域的能源医疗设备先驱 Lumenis Ltd. 在欧洲和中东提供了采用 FocalRF 技术的革命性 NuEra Tight。 NuEraight 为塑身带来了全新的意义,它提供了一种个人化解决方案,可实现非侵入性、射频、减脂、紧肤、脂肪团和皱纹减少,所有功能都在一台装置中。
服务于非侵入性减脂市场的主要公司包括: AbbVie Inc. (Allergan Aesthetics)、Alma Lasers Ltd.、Bausch Health Companies Inc.、Candela Corp.、Cutera Inc.、Cynosure Inc.、Lumenis Be Ltd、BTL Aesthetics , 和别的。市场参与者透过各种策略(包括併购、合作、合作、融资和新产品发布),为市场成长做出了巨大贡献,以保持市场竞争力。例如,2022 年 4 月,皮肤科解决方案提供商 CUTERA, INC. 与消费者支付和融资解决方案提供商 Synchrony 合作,将患者融资选择扩展到美国各地的皮肤科实践。
Title: Global Non-Invasive Fat Reduction Market Size, Share & Trends Analysis Report by Type (Cryolipolysis, Ultrasound, and Others), and by End-User (Hospitals, Cosmetic and Aesthetic Clinics and Others),Forecast Period (2023-2030).
The global non-invasive fat reduction market is anticipated to grow at a CAGR of 7.8% during the Forecast Period (2023-2030). Pivotal factors driving the market growth including the rising prevalence of obesity, growing awareness of health risks, growing demand for minimally invasive procedures and, rising adoption of non-invasive fat reduction procedures. According to the International Society of Aesthetic Plastic Surgery, in 2022, total non-surgical fat reduction procedures performed was 778,716 which was increased from 730,980 in 2021. Further, a survey revealed 85% of people have a season in which they begin to think more about getting rid of stubborn body fat, and for 40% of those people, that season is spring. In addition, 92% of people would like help getting their body ready for summer. Thus, manufacturers are introducing activities to encourage people who are looking for a non-invasive fat reduction treatment. For instance, in April 2023, Allergan Aesthetics, an AbbVie company and the parent company of CoolSculpting® Elite, launched the first ever CoolMonth. CoolMonth activities encouraged people who are considering a non-invasive body contouring treatment to have a conversation with a trusted healthcare provider and an open dialogue about what is realistic for their body contouring goals.
The global non-invasive fat reduction market is segmented on the technology, and end user. Based on the technology, the market is sub-segmented into cryolipolysis, ultrasound and others. Further, on the basis of end user, the market is sub-segmented into hospitals, cosmetic and aesthetic clinics and others. Among the end user, the hospitals sub-segment is anticipated to hold a considerable share of the market, owing to the well-equipped settings, easily accessible, trust and reliability.
Among the technology, the cryolipolysis sub-segment is expected to hold a considerable share of the global non-invasive fat reduction market. The segmental growth is attributed to the minimal side effects, growing demand for safe, fast and non-invasive treatment. According to the study of National Library of Medicine, cryolipolysis is a promising procedure for nonsurgical fat reduction and presents an alternative to liposuction and other invasive methods. This procedure appears to be safe in the short term, with a limited side effect profile, and results in significant fat reduction when used for localized adiposities. It remains unclear whether posttreatment manual massage and multiple treatments in the same anatomic area enhance the efficacy of cryolipolysis.
The global non-invasive fat reduction market is further segmented based on geography including North America (the US, and Canada), Europe (UK, Italy, Spain, Germany, France, and the Rest of Europe), Asia-Pacific (India, China, Japan, South Korea, and Rest of Asia), and the Rest of the World (the Middle East & Africa, and Latin America. Among these, Asia pacific is anticipated to hold a prominent share of the market across the globe, owing to the increasing awareness about the benefits of aesthetic treatments, increasing desire for perfect appearance and confidence through physical characteristics and the rising disposable income and changes in lifestyles owing to urbanization in emerging economies are driving the non-invasive fat reduction market in the Asia Pacific.
Among all regions, the Europe regions is anticipated to grow at a considerable CAGR over the forecast period. The Europe market is growing due to factors such as the rising cases of obesity and the increasing adoption of minimally invasive procedures. According to the International Society of Aesthetic Plastic Surgery 2022 report, in 2022, in the UK, the total number of non-surgical fat reduction procedures performed was 2,142 followed by in Germany the total number of non-surgical fat reduction procedures performed was 26,989, in Italy, the total number of non-surgical fat reduction procedures performed 13,071. Further, the high concentration of market players on Key product launches and acquisitions and partnerships to expand the market in the Europe are some of the factors driving the growth of the non-invasive fat reduction market in the region. For instance, in September 2020, Lumenis Ltd., the pioneer in energy-based medical device company for aesthetic, surgical and ophthalmic applications, provided the revolutionary NuEra Tight with FocalRF technology in Europe and the Middle East. Body Sculpting took a whole new meaning with NuEra tight offering a personalized solution for non-invasive, radio frequency, fat reduction, skin tightening, cellulite and wrinkle reduction, all in one device.
The major companies serving the non-invasive fat reduction market include: AbbVie Inc. (Allergan Aesthetics), Alma Lasers Ltd., Bausch Health Companies Inc., Candela Corp., Cutera Inc., Cynosure Inc., Lumenis Be Ltd, BTL Aesthetics, and others. The market players are considerably contributing to the market growth by the adoption of various strategies including mergers and acquisitions, partnerships, collaborations, funding, and new product launches, to stay competitive in the market. For instance, in April 2022, CUTERA, INC., a provider of dermatological solutions, and Synchrony, a provider of consumer payment and financing solutions, partnered to expand patient financing options to dermatology practices across the US.